Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex)
Saved in:
| Published in: | Cancer Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1871475292638281728 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Cancer Medicine |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:105121 |
| institution | FRELIP |
| journal_source_facet | Cancer Medicine |
| last_indexed | 2026-07-23T03:38:40.373Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) |
| title_alt | Eventos adversos relacionados con el sistema inmunitario y resultados terapéuticos tras la interrupción de inhibidores de puntos de control inmunitario debido a toxicidad en pacientes con melanoma metastásico (University Hospitals Sussex) Événements indésirables liés à l'immunité et résultats thérapeutiques après l'arrêt des inhibiteurs de points de contrôle immunitaires en raison de la toxicité chez les patients atteints de mélanome métastatique (University Hospitals Sussex) Eventos Adversos Relacionados ao Sistema Imunológico e Resultados Terapêuticos Após a Interrupção de Inibidores de Checkpoint Imunológico devido à Toxicidade em Pacientes com Melanoma Metastático (University Hospitals Sussex) |
| title_auth | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) |
| title_es_txt | Eventos adversos relacionados con el sistema inmunitario y resultados terapéuticos tras la interrupción de inhibidores de puntos de control inmunitario debido a toxicidad en pacientes con melanoma metastásico (University Hospitals Sussex) |
| title_fr_txt | Événements indésirables liés à l'immunité et résultats thérapeutiques après l'arrêt des inhibiteurs de points de contrôle immunitaires en raison de la toxicité chez les patients atteints de mélanome métastatique (University Hospitals Sussex) |
| title_full | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) |
| title_fullStr | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) |
| title_full_unstemmed | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) |
| title_pt_txt | Eventos Adversos Relacionados ao Sistema Imunológico e Resultados Terapêuticos Após a Interrupção de Inibidores de Checkpoint Imunológico devido à Toxicidade em Pacientes com Melanoma Metastático (University Hospitals Sussex) |
| title_short | Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex) |
| title_sort | immune‐related adverse events and therapeutic outcomes after stopping immune checkpoint inhibitors due to toxicity among patients with metastatic melanoma (university hospitals sussex) |
| topic | Oncology General Oncology |
| url | https://onlinelibrary.wiley.com/doi/10.1002/cam4.72119?af=R |